How many drugs treat Enterococcus Prostatitis?

Drug Landscape tracks 2 marketed treatments for Enterococcus Prostatitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/enterococcus-prostatitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Enterococcus Prostatitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enterococcus Prostatitis (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Enterococcus Prostatitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Cefradex	cefradine	Bristol-Myers Squibb	cefradine	Matrix metalloproteinase-9		1974-01-01
Cephradin	Cephradin	Sohag University		Matrix metalloproteinase-9, Somatostatin receptor type 4, Bacterial penicillin-binding protein

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Enterococcus Prostatitis
Bristol-Myers Squibb · 1 drug in Enterococcus Prostatitis
Sohag University · 1 drug in Enterococcus Prostatitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Enterococcus Prostatitis:

Cite this brief

Drug Landscape (2026). Enterococcus Prostatitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/enterococcus-prostatitis. Accessed 2026-06-10.

Enterococcus Prostatitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing